Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Thymosin α-1 does not correct F508del-CFTR in cystic fibrosis airway epithelia.

Tomati V, Caci E, Ferrera L, Pesce E, Sondo E, Cholon DM, Quinney NL, Boyles SE, Armirotti A, Ravazzolo R, Galietta LJ, Gentzsch M, Pedemonte N.

JCI Insight. 2019 Apr 4;4(7). pii: 128935. doi: 10.1172/jci.insight.128935. eCollection 2019 Apr 4. No abstract available.

2.

The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model.

Gentzsch M, Cholon DM, Quinney NL, Boyles SE, Martino MEB, Ribeiro CMP.

Eur Respir J. 2018 Dec 20;52(6). pii: 1801133. doi: 10.1183/13993003.01133-2018. Print 2018 Dec. No abstract available.

PMID:
30287473
3.

Generation of renewable mouse intestinal epithelial cell monolayers and organoids for functional analyses.

Moorefield EC, Blue RE, Quinney NL, Gentzsch M, Ding S.

BMC Cell Biol. 2018 Aug 15;19(1):15. doi: 10.1186/s12860-018-0165-0.

4.

Thymosin α-1 does not correct F508del-CFTR in cystic fibrosis airway epithelia.

Tomati V, Caci E, Ferrera L, Pesce E, Sondo E, Cholon DM, Quinney NL, Boyles SE, Armirotti A, Ravazzolo R, Galietta LJ, Gentzsch M, Pedemonte N.

JCI Insight. 2018 Feb 8;3(3). pii: 98699. doi: 10.1172/jci.insight.98699. eCollection 2018 Feb 8. Erratum in: JCI Insight. 2019 Apr 4;4(7):.

5.

Nasospheroids permit measurements of CFTR-dependent fluid transport.

Guimbellot JS, Leach JM, Chaudhry IG, Quinney NL, Boyles SE, Chua M, Aban I, Jaspers I, Gentzsch M.

JCI Insight. 2017 Nov 16;2(22). pii: 95734. doi: 10.1172/jci.insight.95734. eCollection 2017 Nov 16.

6.

Pharmacological Rescue of Conditionally Reprogrammed Cystic Fibrosis Bronchial Epithelial Cells.

Gentzsch M, Boyles SE, Cheluvaraju C, Chaudhry IG, Quinney NL, Cho C, Dang H, Liu X, Schlegel R, Randell SH.

Am J Respir Cell Mol Biol. 2017 May;56(5):568-574. doi: 10.1165/rcmb.2016-0276MA.

7.

Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770.

Gentzsch M, Ren HY, Houck SA, Quinney NL, Cholon DM, Sopha P, Chaudhry IG, Das J, Dokholyan NV, Randell SH, Cyr DM.

Am J Physiol Lung Cell Mol Physiol. 2016 Sep 1;311(3):L550-9. doi: 10.1152/ajplung.00186.2016. Epub 2016 Jul 8.

8.

Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis.

Cholon DM, Quinney NL, Fulcher ML, Esther CR Jr, Das J, Dokholyan NV, Randell SH, Boucher RC, Gentzsch M.

Sci Transl Med. 2014 Jul 23;6(246):246ra96. doi: 10.1126/scitranslmed.3008680.

Supplemental Content

Loading ...
Support Center